Psyence Group Inc.
Psyence Group Inc.
CSE Index:
NoCurrency:
CAD Psyence Group Inc. is a science-led global psychedelic platform, led by experts in neurology, neuroscience and drug development. Psyence has built and operates one of the first federally licensed commercial psilocybin cultivation and production facilities. Psyence is pioneering the use of natural psilocybin for the long-term treatment of psychological trauma and its mental health consequences.
Psyence Group Inc. (PSYG)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Company Info
Address
121 Richmond Street West, Penthouse Suite, 1300
Toronto, ON M5H 2K1
CanadaPhone
1-416-477-1708Email
info@psyence.comWebsite
https://www.psyence.comListing date
Wednesday, January 27, 2021Transfer Agent
Odyssey Trust CompanyEmail
ir@psyence.comAuditor
MNP LLPSEDAR Information
Filing Type
Any
Timeframe
1 week1 month3 month6 month1 yearAll Time
Company Info
Address
121 Richmond Street West, Penthouse Suite, 1300
Toronto, ON M5H 2K1
CanadaPhone
1-416-477-1708Email
info@psyence.comWebsite
https://www.psyence.comListing date
Wednesday, January 27, 2021Transfer Agent
Odyssey Trust CompanyEmail
ir@psyence.comAuditor
MNP LLPCapitalization
Issued & Outstanding:
140815422Reserved for Issuance:
7555711Company Officers
Adri Botha, Chief Financial Officer
News Releases
Bulletins
26/01/2021
2021-0130 – New Listing - Psyence Group Inc. (PSYG)
Le 26 janvier/January 2021
The common shares of Psyence Group Inc. previously listed as Cardinal Capital Partners Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
